-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Market Analysis] Traditional Chinese medicine formula granules are made from traditional Chinese medicine decoction pieces as raw materials, through extraction, separation, concentration, drying, granulation, packaging and other production processes.
New formulations of medicines
.
Compared with traditional Chinese medicine, traditional Chinese medicine granules are more and more favored by the market because they have the advantages of no decoction, convenient carrying and storage, safety and hygiene, and can meet the modern fast-paced life
.
Although traditional Chinese medicine formula granules have many advantages such as being more convenient to use than traditional Chinese medicine decoction pieces, there are also problems such as relatively high prices, so they have not been included in the scope of medical insurance drugs on a large scale
.
Even after the production of traditional Chinese medicine formula granules is released in early 2021, supporting policies such as relevant medical insurance access have not been implemented
.
However, this situation has now begun to change.
On October 11, 2021, the State Food and Drug Administration announced the "Letter on the Reply to Proposal No.
4117 of the Fourth Session of the 13th National Committee of the Chinese People's Political Consultative Conference", disclosing that relevant departments have It was decided to appropriately include traditional Chinese medicine formula granules in the scope of national medical insurance reimbursement
.
Under the guidance of the policy, the coverage of traditional Chinese medicine formula granules in the national medical insurance has been continuously expanded
.
At present, Beijing, Zhejiang, Hebei, Hunan and other provinces have begun to include traditional Chinese medicine formula granules into the scope of medical insurance payment
.
For example, on October 27, 2021, the Sichuan Provincial Food and Drug Administration issued a notice on printing and distributing the "Implementation Rules for the Administration of Traditional Chinese Medicine Formula Granules in Sichuan Province".
Explain and stipulate that the notice will be implemented from November 1
.
On the 29th, the Beijing Municipal Drug Administration, the Beijing Municipal Administration of Traditional Chinese Medicine, the Beijing Municipal Health Commission, and the Beijing Municipal Medical Security Bureau also jointly issued the "Implementation Rules for the Administration of Traditional Chinese Medicine Formula Granules in Beijing (Trial)", which clearly will strengthen the The management of traditional Chinese medicine formula granules will guide the healthy development of the industry and better meet the clinical needs of traditional Chinese medicine, and will be implemented on November 1
.
Among them, it is worth mentioning that some time ago, the Fujian Provincial Medical Insurance Bureau website released the "Notice of Fujian Provincial Medical Insurance Bureau on Doing a Good Job in the Management of Medical Insurance for Chinese Medicine Formula Granules" (hereinafter referred to as the "Notice")
.
According to the "Notice", qualified Chinese medicine formula granules, after being reviewed by experts, will be included in the payment scope of the basic medical insurance fund of Fujian Province according to 70% of the sales price, and the limited payment scope of the corresponding Chinese medicine decoction pieces will be implemented with reference to the regulations
.
In addition, the traditional Chinese medicine formula granules purchased by public medical institutions according to the regulations are temporarily sold at an increase of no more than 15% of the actual purchase price
.
On the whole, Fujian's policy basically covers all the varieties of traditional Chinese medicine formula granules currently sold in public hospitals in the province, which means that the category of formula granules is included in the scope of medical insurance
.
The industry believes that Fujian is one step ahead, which may bring more opportunities to the entire industry
.
The industry expects that with the expansion of hospitals and medical insurance coverage, the traditional Chinese medicine formula granule industry is expected to continue to grow
.
By 2030, the market size of traditional Chinese medicine formula granules may reach 100 billion yuan, which will attract more pharmaceutical companies to accelerate the rapid development of this fast-growing market
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
New formulations of medicines
.
Compared with traditional Chinese medicine, traditional Chinese medicine granules are more and more favored by the market because they have the advantages of no decoction, convenient carrying and storage, safety and hygiene, and can meet the modern fast-paced life
.
Although traditional Chinese medicine formula granules have many advantages such as being more convenient to use than traditional Chinese medicine decoction pieces, there are also problems such as relatively high prices, so they have not been included in the scope of medical insurance drugs on a large scale
.
Even after the production of traditional Chinese medicine formula granules is released in early 2021, supporting policies such as relevant medical insurance access have not been implemented
.
However, this situation has now begun to change.
On October 11, 2021, the State Food and Drug Administration announced the "Letter on the Reply to Proposal No.
4117 of the Fourth Session of the 13th National Committee of the Chinese People's Political Consultative Conference", disclosing that relevant departments have It was decided to appropriately include traditional Chinese medicine formula granules in the scope of national medical insurance reimbursement
.
Under the guidance of the policy, the coverage of traditional Chinese medicine formula granules in the national medical insurance has been continuously expanded
.
At present, Beijing, Zhejiang, Hebei, Hunan and other provinces have begun to include traditional Chinese medicine formula granules into the scope of medical insurance payment
.
For example, on October 27, 2021, the Sichuan Provincial Food and Drug Administration issued a notice on printing and distributing the "Implementation Rules for the Administration of Traditional Chinese Medicine Formula Granules in Sichuan Province".
Explain and stipulate that the notice will be implemented from November 1
.
On the 29th, the Beijing Municipal Drug Administration, the Beijing Municipal Administration of Traditional Chinese Medicine, the Beijing Municipal Health Commission, and the Beijing Municipal Medical Security Bureau also jointly issued the "Implementation Rules for the Administration of Traditional Chinese Medicine Formula Granules in Beijing (Trial)", which clearly will strengthen the The management of traditional Chinese medicine formula granules will guide the healthy development of the industry and better meet the clinical needs of traditional Chinese medicine, and will be implemented on November 1
.
Among them, it is worth mentioning that some time ago, the Fujian Provincial Medical Insurance Bureau website released the "Notice of Fujian Provincial Medical Insurance Bureau on Doing a Good Job in the Management of Medical Insurance for Chinese Medicine Formula Granules" (hereinafter referred to as the "Notice")
.
According to the "Notice", qualified Chinese medicine formula granules, after being reviewed by experts, will be included in the payment scope of the basic medical insurance fund of Fujian Province according to 70% of the sales price, and the limited payment scope of the corresponding Chinese medicine decoction pieces will be implemented with reference to the regulations
.
In addition, the traditional Chinese medicine formula granules purchased by public medical institutions according to the regulations are temporarily sold at an increase of no more than 15% of the actual purchase price
.
On the whole, Fujian's policy basically covers all the varieties of traditional Chinese medicine formula granules currently sold in public hospitals in the province, which means that the category of formula granules is included in the scope of medical insurance
.
The industry believes that Fujian is one step ahead, which may bring more opportunities to the entire industry
.
The industry expects that with the expansion of hospitals and medical insurance coverage, the traditional Chinese medicine formula granule industry is expected to continue to grow
.
By 2030, the market size of traditional Chinese medicine formula granules may reach 100 billion yuan, which will attract more pharmaceutical companies to accelerate the rapid development of this fast-growing market
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
